FluoroPharma Medical, Inc.
FPMI
$0.0001
$0.000.00%
OTC PK
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Net Income | -133.12% | 152.32% | 53.32% | -24.18% | -1,307.24% |
| Total Depreciation and Amortization | -1.80% | 0.91% | 0.00% | -0.90% | 3.74% |
| Total Amortization of Deferred Charges | 149.06% | -61.51% | -21.72% | -8.77% | 81.46% |
| Total Other Non-Cash Items | 35.30% | -204.15% | -149.79% | 1,682.21% | 102.93% |
| Change in Net Operating Assets | 395.61% | -112.99% | 199.91% | 1,006.20% | 61.70% |
| Cash from Operations | 78.08% | -431.25% | 140.63% | 59.29% | -4.22% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | -- |
| Total Debt Issued | 43.33% | -28.57% | 40.00% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 81.48% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -87.50% | 46.67% | 74.58% | -115.17% | 125.47% |
| Cash from Financing | -23.93% | -28.44% | 44.69% | 499.17% | -101.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.26% | -203.73% | 247.02% | 75.28% | -180.24% |